METHODS AND SYSTEMS FOR BLOOD FLOW MEASUREMENT USING DOPPLER OPTICAL COHERENCE TOMOGRAPHY
    2.
    发明公开
    METHODS AND SYSTEMS FOR BLOOD FLOW MEASUREMENT USING DOPPLER OPTICAL COHERENCE TOMOGRAPHY 有权
    血流测量的方法和系统多普勒光学相干断层扫描

    公开(公告)号:EP2144566A2

    公开(公告)日:2010-01-20

    申请号:EP08799761.5

    申请日:2008-04-10

    IPC分类号: A61B8/00

    CPC分类号: A61B3/102

    摘要: This invention provides methods for non-invasive, real-time measuring and/or monitoring of local blood flow in a subject. Methods of the invention generally include the steps of obtaining Doppler shift images of at least two planes intersecting blood vessels at the scanned location; determining Doppler angles using the Doppler shift images; and then using the Doppler angles thus determined together with the Doppler shift signals to arrive at a measure of the volumetric blood flow. Also provided are systems and software for performing the methods.

    METHODS AND AGENTS FOR ENHANCING WOUND HEALING

    公开(公告)号:EP3598976A1

    公开(公告)日:2020-01-29

    申请号:EP19195610.1

    申请日:2011-05-06

    摘要: This invention discloses a method of inducing expression of full-length collagen 7 in cells that contain nonsense mutations in the COL7A1 gene by treating the cell with an aminoglycoside such as G418, gentamicin, and paromomycin. Also provided is a method of treating DEB due to nonsense mutation in the COL7A1 gene by administering a composition containing an effective amount of an aminoglycoside. Also provided is a novel composition useful to treating conditions due to nonsense mutation in the COL7A1 gene, containing an aminoglycoside, a C7, a min-C7 or both; and a pharmaceutically acceptable carrier.

    METHODS AND AGENTS FOR ENHANCING WOUND HEALING
    8.
    发明公开
    METHODS AND AGENTS FOR ENHANCING WOUND HEALING 审中-公开
    方式和途径改善伤口愈合

    公开(公告)号:EP2566483A1

    公开(公告)日:2013-03-13

    申请号:EP11778468.6

    申请日:2011-05-06

    IPC分类号: A61K31/7008

    摘要: This invention discloses a method of inducing expression of full-length collagen 7 in cells that contain nonsense mutations in the
    COL7A1 gene by treating the cell with an aminoglycoside such as G418, gentamicin, and paromomycin. Also provided is a method of treating DEB due to nonsense mutation in the
    COL7A1 gene by administering a composition containing an effective amount of an aminoglycoside. Also provided is a novel composition useful to treating conditions due to nonsense mutation in the
    COL7A1 gene, containing an aminoglycoside, a C7, a min-C7 or both; and a pharmaceutically acceptable carrier.